Showing results 1 to 20 of 64
next >
| Issue Date | Title | Author(s) |
| 2019 | ALBUMIN AND PLATELET AFTER SIX MONTHS OF ANTIVIRAL THERAPY ARE INDEPENDENT SERUM MARKERS TO PREDICT LIVER RELATED EVENTS IN HBV-RELATED COMPENSATED LIVER CIRRHOSIS | Wu, Xiaoning; Zhou, Jialing; Meng, Tongtong; Sun, Yameng; Wang, Bingqiong; Piao, Hongxin; Ding, Huiguo; Xu, Xiaoyuan; Jiang, Wei; Chen, Yongpeng; Xie, Wen; Ma, Anlin; Cheng, Jun, Sr.; Cheng, Jilin; Zhang, Mingxiang; Guan, Qiushuang; Chen, Shuyan; Shi, Yiwen; Duan, Weijia; Kong, Yuanyuan; Ou, Xiaojuan; You, Hong; Jia, Jidong |
| 2019 | All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china | Wei, Lai; Xu, Xiaoyuan; Guan, Yujuan; Zheng, Sujun; Sheng, Ji-Fang; Yang, Xingxiang; Ma, Yuanji; Huang, Yan; Kang, Yi; Wen, Xiaofeng; Li, Jun; Tan, Youwen; He, Qing; Xie, Qing; Wang, Maorong; An, Ping; Gong, Guozhong; Liu, Huimin; Ning, Qin; Hua, Rui; Ning, Bo; Xie, Wen; Zhang, Jiming; Huang, Wenxiang; Yang, Yongfeng; Lin, Minghua; Zhao, Yingren; Yu, Yanhong; Jia, Ji-Dong; Yang, Dongliang; Chen, Liang; Ye, Yinong; Nan, Yuemin; Gong, Zuojong; Zhang, Quan; Hu, Peng; Wang, Fu-Sheng; Li, Yongguo; Li, Dongliang; Jia, Zhansheng; Hou, Jinlin; Chen, Chengwei; Wu, Jinzi |
| Nov-2020 | ANTIVIRAL THERAPY IMPROVES LONG-TERM HEALTH RELATED QUALITY OF LIFE IN COMPENSATED HBV-CIRRHOSIS PATIENTS | Wu, Xiaoning; Hong, Jia; Zhou, Jialing; Sun, Yameng; Ding, Huiguo; Xie, Wen; Piao, Hongxin; Xu, Xiaoyuan; Jiang, Wei; Feng, Bo; Xu, Mingyi; Cheng, Jilin; Ou, Xiaojuan; Jia, Jidong; You, Hong |
| 2016 | Association of IL28B Genotypes and Baseline Serum Interferon-gamma-Inducible-Protein-10 Levels with Treatment Response in Hepatitis C Virus Patients in China | Zhang, Renwen; Shoo, Cuiping; Huo, Na; Li, Minran; Xu, Xiaoyuan |
| 2018 | Baseline and Treatment Profiles of Patients Recruited in China Registry of Hepatitis B | Shan, Shan; You, Hong; Niu, Junqi; Shang, Jia; Zhang, Yuexin; Ren, Hong; Tang, Hong; Ding, Huiguo; Zhang, Lingyi; Nan, Yuemin; Han, Tao; Wang, Xiaozhong; Liu, Xiaoqing; Dou, Xiaoguang; Xu, Xiaoyuan; Wei, Lai; Hou, Jinlin; Duan, Zhongping; Zhuang, Hui; Kong, Yuanyuan; Jia, Jidong |
| 2018 | Baseline and Treatment Profiles of Patients Recruited in China Registry of Hepatitis B | Shan, Shan; You, Hong; Niu, Junqi; Shang, Jia; Zhang, Yuexin; Ren, Hong; Tang, Hong; Ding, Huiguo; Zhang, Lingyi; Nan, Yuemin; Han, Tao; Wang, Xiaozhong; Liu, Xiaoqing; Dou, Xiaoguang; Xu, Xiaoyuan; Wei, Lai; Hou, Jinlin; Duan, Zhongping; Zhuang, Hui; Kong, Yuanyuan; Jia, Jidong |
| Oct-2023 | CARVEDILOL PLUS NUCS TO PREVENT THE PROGRESSION OF ESOPHAGEAL VARICES IN VIROLOGICAL SUPPRESSED HBV-CIRRHOSIS PATIENTS: A RANDOMISED, OPEN-LABEL TRIAL | Wang, Bingqiong; Zhou, Jialing; Wu, Xiaoning; Sun, Yameng; Li, Lei; Li, Ping; Li, Minghui; Jiang, Wei; Xu, Mingyi; Feng, Bo; Xu, Xiaoyuan; Cheng, Jilin; Xie, Wen; Han, Tao; Wang, Xiaozhong; Li, Hai; Piao, Hongxin; Zhao, Xinyu; Chen, Shuyan; Meng, Tongtong; Guan, Qiushuang; Meng, Fandong; Kong, Yuanyuan; Ou, Xiaojuan; Jia, Jidong; You, Hong |
| 2017 | Changes in renal function indices in cirrhotic chronic hepatitis C patients treated with sofosbuvir-containing regimens | Chen, Jianhong; Zhang, Xiaxia; Luo, Hao; Wu, Chihong; Yu, Min; Liu, Dan; Xi, Hongli; Zhou, Yihang; An, Yaoyu; Xu, Xiaoyuan |
| 2017 | Characterization of hepatitis B virus (HBV) preS/S gene mutations in blood donors with occult HBV infection in the Baoji area of North China | Liao, Hao; Liu, Yan; Chen, Jianhong; Ding, Weiping; Li, Xiaodong; Xu, Zhihui; Yang, Yuan; Chen, Rongjuan; Si, Lanlan; Xu, Xiaoyuan; Guo, Jianxun; Xu, Dongping |
| Mar-2020 | China Registry of Hepatitis B (CR-HepB): Protocol and implementation of a nationwide hospital-based registry of hepatitis B | Shan, Shan; Wei, Wei; Kong, Yuanyuan; Niu, Junqi; Shang, Jia; Xie, Wen; Zhang, Yuexin; Ren, Hong; Tang, Hong; Ding, Huiguo; Nan, Yuemin; Dou, Xiaoguang; Han, Tao; Xu, Xiaoyuan; Duan, Zhongping; Wei, Lai; Hou, Jinlin; Zhuang, Hui; You, Hong; Jia, Jidong |
| 2019 | Chinese guidelines on the management of ascites and its related complications in cirrhosis | Xu, Xiaoyuan; Duan, Zhongping; Ding, Huiguo; Li, Wengang; Jia, Jidong; Wei, Lai; Linghu, Enqiang; Zhuang, Hui |
| 9-Jul-2024 | Chinese guidelines on the management of ascites in cirrhosis Chinese Society of Hepatology, Chinese Medical Association | Xu, Xiaoyuan; Ding, Huiguo; Jia, Jidong; Wei, Lai; Duan, Zhongping; Tang, Chengwei; Linghu, Enqiang; Nan, Yuemin; Han, Ying; Xu, Jinghang; Zhuang, Hui |
| 17-Feb-2025 | Chinese Guidelines on the Management of Hepatic Encephalopathy in Cirrhosis (2024) | Xu, Xiaoyuan; Ding, Huiguo; Li, Wengang; Han, Ying; Guan, Yujuan; Xu, Jinghang; Han, Yifan; Jia, Jidong; Wei, Lai; Duan, Zhongping; Nan, Yuemin; Zhuang, Hui; Chinese Society Hepatology; Chinese Medical Association |
| Nov-2021 | Consensus on the secondary prevention of primary liver cancer | Nan, Yuemin; Xu, Xiaoyuan; Gao, Yanhang; Wang, Rongqi; Li, Wengang; Yang, Ming; Liu, Lingdi; Duan, Zhongping; Jia, Jidong; Wei, Lai; Zhuang, Hui |
| Jan-2022 | Consensus on the secondary prevention of primary liver cancer (vol 15, pg 1289, 2021) | Nan, Yuemin; Xu, Xiaoyuan; Gao, Yanhang; Wang, Rongqi; Li, Wengang; Yang, Ming; Liu, Lingdi; Duan, Zhongping; Jia, Jidong; Wei, Lai; Zhuang, Hui |
| 2023 | Consensus on the tertiary prevention of primary liver cancer | Nan, Yuemin; Xu, Xiaoyuan; Dong, Shiming; Yang, Ming; Li, Ling; Zhao, Suxian; Duan, Zhongping; Jia, Jidong; Wei, Lai; Zhuang, Hui; Chinese Med Assoc; Chinese Society Hepatology |
| Jun-2023 | Cost-effectiveness of expanded antiviral treatment for chronic hepatitis B virus infection in China: an economic evaluation | Zhang, Sihui; Wang, Chao; Liu, Bei; Lu, Qing-Bin; Shang, Jia; Zhou, Yihua; Jia, Jidong; Xu, Xiaoyuan; Rao, Huiying; Han, Bingfeng; Zhao, Tianshuo; Chen, Linyi; Xie, Mingzhu; Cui, Jiahao; Du, Juan; Zeng, Jing; Huang, Ninghua; Liu, Yaqiong; Zhang, Lei; Zhuang, Hui; Cui, Fuqiang |
| Jun-2023 | Cost-effectiveness of expanded antiviral treatment for chronic hepatitis B virus infection in China: an economic evaluation | Zhang, Sihui; Wang, Chao; Liu, Bei; Lu, Qing-Bin; Shang, Jia; Zhou, Yihua; Jia, Jidong; Xu, Xiaoyuan; Rao, Huiying; Han, Bingfeng; Zhao, Tianshuo; Chen, Linyi; Xie, Mingzhu; Cui, Jiahao; Du, Juan; Zeng, Jing; Huang, Ninghua; Liu, Yaqiong; Zhang, Lei; Zhuang, Hui; Cui, Fuqiang |
| 5-Oct-2020 | Decrease in Chitinase 3-Like Protein 1 Levels Reflects Improvement in Liver Fibrosis after HCV Eradication | Kang, Qian; Chen, Jianhong; Luo, Hao; Tan, Ning; Gao, Hui; Zhang, Xiaxia; Yu, Min; Liu, Dan; Xi, Hongli; An, Yaoyu; Han, Yifan; Cheng, Ran; Xu, Xiaoyuan |
| 2012 | Different HCV Genotype Distributions of HIV-Infected Individuals in Henan and Guangxi, China | Tian, Di; Li, Lin; Liu, Yongjian; Li, Hanping; Xu, Xiaoyuan; Li, Jingyun |
